“…The generally accepted correlate of protection against meningococcal infection is the presence of antibodies with the ability to activate complement-mediated killing of meningococci (15). Several studies with recombinant meningococcal PorA and Opc proteins, as well as with purified PI porin from Neisseria gonorrhoeae, have clearly demonstrated that the production of bactericidal antibodies was dependent on refolding of the protein to induce native conformation, which could be achieved by incorporation either into artificial membranes (liposomes) (8,20,22,30,29,42,44) or detergent micelles (21,22,43).…”